TG Therapeutics | TGTX - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
AbbVie USD 645M 69M 2026-03
Alaunos Therapeutics USD 1.07M 215K 2023-06
Amgen USD 657M 4M 2026-03
Ardelyx USD 5.6M 160K 2026-03
Arrowhead Research USD 22.5M 811K 2025-12
Bayer EUR 675M 87M 2025-12
Biogen USD 72.6M 12.6M 2025-06
Corcept Therapeutics USD 814.88M 809.46M 2026-03
Curis USD 178K 441K 2023-12
Gilead Sciences USD 240M 15M 2026-03
J&J USD 43M 25M 2026-03
Karyopharm Therapeutics USD 12.62M 1.24M 2025-12
Novartis USD 343M 39M 2026-03
Novavax USD 5.82M 342K 2025-12
PTC Therapeutics USD 2.87B 2.82B 2026-03
Puma Biotechnology USD 3.37M 11K 2024-06
Regeneron Pharmaceuticals USD 12.9M 700K 2026-03
Roche Holding CHF 304M 7.5M 2025-06
TG Therapeutics USD 7.67M 1.13M 2026-03
Verastem USD 415K 733K 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12